| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |